Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
RADCOMP
Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
- NCT02603341 ↗
- Active, not recruiting
- Abramson Cancer Center at Penn Medicine
- Deep
We haven't built an HCP commentary report on RADCOMP (Breast Cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on RADCOMP so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 34 | |
| Podcasts | 6 | |
| YouTube | 5 | |
| Bluesky threads | 1 |
The trial
ClinicalTrials.gov- Official title
- Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Photon; Proton
- Arms
- Photon · Active comparator
- Proton · Active comparator
- Enrollment
- 1,238 (estimated)
- Primary outcomes
- Effectiveness of proton therapy vs. photon therapy
- Sponsor
- Abramson Cancer Center at Penn Medicine with Patient-Centered Outcomes Research Institute
- Start
- Apr 6, 2016
- Primary completion
- Nov 2036 (estimated)
- Results posted
- No
- Registry record
- NCT02603341 · updated Nov 6, 2025
Publications
linked from the registry- Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, Wright JL, MacDonald SM, Cahlon O, Baas C, Braunstein LZ, Fang LC, Freedman GM, Jimenez RB, Kesslering CM, Mishra MV, Mutter RW, Ohri N, Rosen LR, Urbanic JJ, Jagsi R, Mitchell SA, Bekelman JE, Cella D; Study Group Investigators:. Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):149-161. doi: 10.1016/j.ijrobp.2024.03.020. Epub 2024 May 13. PubMed 38739047
- Bekelman JE, Lu H, Pugh S, Baker K, Berg CD, Berrington de Gonzalez A, Braunstein LZ, Bosch W, Chauhan C, Ellenberg S, Fang LC, Freedman GM, Hahn EA, Haffty BG, Khan AJ, Jimenez RB, Kesslering C, Ky B, Lee C, Lu HM, Mishra MV, Mullins CD, Mutter RW, Nagda S, Pankuch M, Powell SN, Prior FW, Schupak K, Taghian AG, Wilkinson JB, MacDonald SM, Cahlon O; RadComp (Radiotherapy Comparative Effectiveness Consortium). Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol. BMJ Open. 2019 Oct 15;9(10):e025556. doi: 10.1136/bmjopen-2018-025556. PubMed 31619413